» Authors » Rama Kandasamy

Rama Kandasamy

Explore the profile of Rama Kandasamy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 291
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozturk A, Chan M, Khan J, Hu N, McMullan B, Britton P, et al.
J Infect Dis . 2024 Nov; PMID: 39484989
Background: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) associated hospitalisations in children. It is unclear if hospitalized RSV-ALRI differs in clinically from other...
2.
El Safadi D, El Safadi D, Hitchins L, Hitchins L, Howard A, Howard A, et al.
J Infect Dis . 2024 Jul; 231(1):e17-e27. PMID: 39013016
Background: Pneumococcal carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is not well understood. Methods: Nasal wash samples from adults without close contact with young children...
3.
Kandasamy R, Gurung M, Shrestha S, Gautam M, Kelly S, Thorson S, et al.
Vaccine . 2024 May; 42(19):4066-4071. PMID: 38789369
Background: Carriage studies are an efficient means for assessing pneumococcal conjugate vaccine effect in settings where pneumococcal disease surveillance programmes are not well established. In this study the effect of...
4.
Carter M, Shrestha S, OReilly P, Gurung P, Gurung M, Thorson S, et al.
Pediatr Infect Dis J . 2024 May; 43(2):e67-e70. PMID: 38758207
We evaluated whether the quantification of IgG to pneumococcal capsular polysaccharides is an accurate diagnostic test for pneumococcal infection in children with pneumonia in Nepal. Children with pneumococcal pneumonia did...
5.
Stubbs H, Palasanthiran P, Koirala A, Lee A, Duguid R, Brogan D, et al.
Vaccine . 2024 Mar; 42(10):2661-2671. PMID: 38490823
Objective: Prior experience of an adverse event following immunisation is a known barrier to vaccination. Limited Australian data evaluating adverse event recurrence among children exists to inform clinical decisions. We...
6.
Lim S, Chan M, Hu N, McMullan B, Britton P, Bartlett A, et al.
Pediatr Infect Dis J . 2024 Feb; 43(6):511-517. PMID: 38377461
Background: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) in children <2 years of age. Currently, there are limited data on risk factors for...
7.
Tiley K, Ratcliffe H, Voysey M, Jefferies K, Sinclair G, Carr M, et al.
J Infect Dis . 2022 Sep; 227(5):610-621. PMID: 36130327
Background: Monitoring changes in pharyngeal carriage of pneumococcus in children following 13-valent pneumococcal conjugate vaccine (PCV13) introduction in the United Kingdom in 2010 informs understanding of patterns of invasive pneumococcal...
8.
Shrestha S, Gurung M, Amatya P, Bijukchhe S, Bose A, Carter M, et al.
Lancet Glob Health . 2022 Sep; 10(10):e1494-e1504. PMID: 36113533
Background: In Nepal, Streptococcus pneumoniae (pneumococcus) is a common cause of bacterial pneumonia in children, and is a major health concern. There are few data on the effect of vaccination...
9.
Lo S, Mellor K, Cohen R, Alonso A, Belman S, Kumar N, et al.
Lancet Microbe . 2022 Aug; 3(10):e735-e743. PMID: 35985351
Background: Serotype 24F is one of the emerging pneumococcal serotypes after the introduction of pneumococcal conjugate vaccine (PCV). We aimed to identify lineages driving the increase of serotype 24F in...
10.
Kandasamy R, Lo S, Gurung M, Carter M, Gladstone R, Lees J, et al.
Lancet Microbe . 2022 Jul; 3(7):e503-e511. PMID: 35779566
Background: Pneumococcal disease is a leading cause of bacterial pneumonia and invasive bacterial disease among children globally. The reason some strains of pneumococci are more likely to cause disease, and...